Cognitive profile of LRRK2-related Parkinson's disease

Sindhu Srivatsal, Brenna Cholerton, James B. Leverenz, Zbigniew K. Wszolek, Ryan J. Uitti, Dennis W. Dickson, Daniel Weintraub, John Q. Trojanowski, Vivianna M. Van Deerlin, Joseph Quinn, Kathryn (Kathy) Chung, Amie Peterson, Stewart A. Factor, Cathy Wood-Siverio, Jennifer G. Goldman, Glenn T. Stebbins, Bryan Bernard, Beate Ritz, Rebecca Rausch, Alberto J. Espay & 13 others Fredy J. Revilla, Johnna Devoto, Liana S. Rosenthal, Ted M. Dawson, Marilyn S. Albert, Ignacio F. Mata, Shu Ching Hu, Kathleen S. Montine, Catherine Johnson, Thomas J. Montine, Karen L. Edwards, Jing Zhang, Cyrus P. Zabetian

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Background: Increasing evidence suggests that genetic factors play a role in the variability associated with cognitive performance in Parkinson's disease (PD). Mutations in the LRRK2 gene are the most common cause of monogenic PD; however, the cognitive profile of LRRK2-related PD is not well-characterized. Methods: A cohort of 1,447 PD patients enrolled in the PD Cognitive Genetics Consortium was screened for LRRK2 mutations and completed detailed cognitive testing. Associations between mutation carrier status and cognitive test scores were assessed using linear regression models. Results: LRRK2 mutation carriers (n=29) demonstrated better performance on the Mini Mental State Examination (P=0.03) and the Letter-Number Sequencing Test (P=0.005). A smaller proportion of LRRK2 carriers were demented (P=0.03). Conclusions: Our cross-sectional study demonstrates better performance on certain cognitive tests, as well as lower rates of dementia in LRRK2-related PD. Future longitudinal studies are needed to determine whether LRRK2 mutation carriers exhibit slower cognitive decline.

Original languageEnglish (US)
Pages (from-to)728-733
Number of pages6
JournalMovement Disorders
Volume30
Issue number5
DOIs
StatePublished - Apr 15 2015

Fingerprint

Parkinson Disease
Mutation
Linear Models
Longitudinal Studies
Dementia
Cross-Sectional Studies
Genes

Keywords

  • Cognition
  • LRRK2
  • Neuropsychological tests
  • Parkinson's disease
  • Working memory

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Srivatsal, S., Cholerton, B., Leverenz, J. B., Wszolek, Z. K., Uitti, R. J., Dickson, D. W., ... Zabetian, C. P. (2015). Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders, 30(5), 728-733. https://doi.org/10.1002/mds.26161

Cognitive profile of LRRK2-related Parkinson's disease. / Srivatsal, Sindhu; Cholerton, Brenna; Leverenz, James B.; Wszolek, Zbigniew K.; Uitti, Ryan J.; Dickson, Dennis W.; Weintraub, Daniel; Trojanowski, John Q.; Van Deerlin, Vivianna M.; Quinn, Joseph; Chung, Kathryn (Kathy); Peterson, Amie; Factor, Stewart A.; Wood-Siverio, Cathy; Goldman, Jennifer G.; Stebbins, Glenn T.; Bernard, Bryan; Ritz, Beate; Rausch, Rebecca; Espay, Alberto J.; Revilla, Fredy J.; Devoto, Johnna; Rosenthal, Liana S.; Dawson, Ted M.; Albert, Marilyn S.; Mata, Ignacio F.; Hu, Shu Ching; Montine, Kathleen S.; Johnson, Catherine; Montine, Thomas J.; Edwards, Karen L.; Zhang, Jing; Zabetian, Cyrus P.

In: Movement Disorders, Vol. 30, No. 5, 15.04.2015, p. 728-733.

Research output: Contribution to journalArticle

Srivatsal, S, Cholerton, B, Leverenz, JB, Wszolek, ZK, Uitti, RJ, Dickson, DW, Weintraub, D, Trojanowski, JQ, Van Deerlin, VM, Quinn, J, Chung, KK, Peterson, A, Factor, SA, Wood-Siverio, C, Goldman, JG, Stebbins, GT, Bernard, B, Ritz, B, Rausch, R, Espay, AJ, Revilla, FJ, Devoto, J, Rosenthal, LS, Dawson, TM, Albert, MS, Mata, IF, Hu, SC, Montine, KS, Johnson, C, Montine, TJ, Edwards, KL, Zhang, J & Zabetian, CP 2015, 'Cognitive profile of LRRK2-related Parkinson's disease', Movement Disorders, vol. 30, no. 5, pp. 728-733. https://doi.org/10.1002/mds.26161
Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW et al. Cognitive profile of LRRK2-related Parkinson's disease. Movement Disorders. 2015 Apr 15;30(5):728-733. https://doi.org/10.1002/mds.26161
Srivatsal, Sindhu ; Cholerton, Brenna ; Leverenz, James B. ; Wszolek, Zbigniew K. ; Uitti, Ryan J. ; Dickson, Dennis W. ; Weintraub, Daniel ; Trojanowski, John Q. ; Van Deerlin, Vivianna M. ; Quinn, Joseph ; Chung, Kathryn (Kathy) ; Peterson, Amie ; Factor, Stewart A. ; Wood-Siverio, Cathy ; Goldman, Jennifer G. ; Stebbins, Glenn T. ; Bernard, Bryan ; Ritz, Beate ; Rausch, Rebecca ; Espay, Alberto J. ; Revilla, Fredy J. ; Devoto, Johnna ; Rosenthal, Liana S. ; Dawson, Ted M. ; Albert, Marilyn S. ; Mata, Ignacio F. ; Hu, Shu Ching ; Montine, Kathleen S. ; Johnson, Catherine ; Montine, Thomas J. ; Edwards, Karen L. ; Zhang, Jing ; Zabetian, Cyrus P. / Cognitive profile of LRRK2-related Parkinson's disease. In: Movement Disorders. 2015 ; Vol. 30, No. 5. pp. 728-733.
@article{aae5fb66c8f74fbbb0b99c53e32bed7d,
title = "Cognitive profile of LRRK2-related Parkinson's disease",
abstract = "Background: Increasing evidence suggests that genetic factors play a role in the variability associated with cognitive performance in Parkinson's disease (PD). Mutations in the LRRK2 gene are the most common cause of monogenic PD; however, the cognitive profile of LRRK2-related PD is not well-characterized. Methods: A cohort of 1,447 PD patients enrolled in the PD Cognitive Genetics Consortium was screened for LRRK2 mutations and completed detailed cognitive testing. Associations between mutation carrier status and cognitive test scores were assessed using linear regression models. Results: LRRK2 mutation carriers (n=29) demonstrated better performance on the Mini Mental State Examination (P=0.03) and the Letter-Number Sequencing Test (P=0.005). A smaller proportion of LRRK2 carriers were demented (P=0.03). Conclusions: Our cross-sectional study demonstrates better performance on certain cognitive tests, as well as lower rates of dementia in LRRK2-related PD. Future longitudinal studies are needed to determine whether LRRK2 mutation carriers exhibit slower cognitive decline.",
keywords = "Cognition, LRRK2, Neuropsychological tests, Parkinson's disease, Working memory",
author = "Sindhu Srivatsal and Brenna Cholerton and Leverenz, {James B.} and Wszolek, {Zbigniew K.} and Uitti, {Ryan J.} and Dickson, {Dennis W.} and Daniel Weintraub and Trojanowski, {John Q.} and {Van Deerlin}, {Vivianna M.} and Joseph Quinn and Chung, {Kathryn (Kathy)} and Amie Peterson and Factor, {Stewart A.} and Cathy Wood-Siverio and Goldman, {Jennifer G.} and Stebbins, {Glenn T.} and Bryan Bernard and Beate Ritz and Rebecca Rausch and Espay, {Alberto J.} and Revilla, {Fredy J.} and Johnna Devoto and Rosenthal, {Liana S.} and Dawson, {Ted M.} and Albert, {Marilyn S.} and Mata, {Ignacio F.} and Hu, {Shu Ching} and Montine, {Kathleen S.} and Catherine Johnson and Montine, {Thomas J.} and Edwards, {Karen L.} and Jing Zhang and Zabetian, {Cyrus P.}",
year = "2015",
month = "4",
day = "15",
doi = "10.1002/mds.26161",
language = "English (US)",
volume = "30",
pages = "728--733",
journal = "Movement Disorders",
issn = "0885-3185",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Cognitive profile of LRRK2-related Parkinson's disease

AU - Srivatsal, Sindhu

AU - Cholerton, Brenna

AU - Leverenz, James B.

AU - Wszolek, Zbigniew K.

AU - Uitti, Ryan J.

AU - Dickson, Dennis W.

AU - Weintraub, Daniel

AU - Trojanowski, John Q.

AU - Van Deerlin, Vivianna M.

AU - Quinn, Joseph

AU - Chung, Kathryn (Kathy)

AU - Peterson, Amie

AU - Factor, Stewart A.

AU - Wood-Siverio, Cathy

AU - Goldman, Jennifer G.

AU - Stebbins, Glenn T.

AU - Bernard, Bryan

AU - Ritz, Beate

AU - Rausch, Rebecca

AU - Espay, Alberto J.

AU - Revilla, Fredy J.

AU - Devoto, Johnna

AU - Rosenthal, Liana S.

AU - Dawson, Ted M.

AU - Albert, Marilyn S.

AU - Mata, Ignacio F.

AU - Hu, Shu Ching

AU - Montine, Kathleen S.

AU - Johnson, Catherine

AU - Montine, Thomas J.

AU - Edwards, Karen L.

AU - Zhang, Jing

AU - Zabetian, Cyrus P.

PY - 2015/4/15

Y1 - 2015/4/15

N2 - Background: Increasing evidence suggests that genetic factors play a role in the variability associated with cognitive performance in Parkinson's disease (PD). Mutations in the LRRK2 gene are the most common cause of monogenic PD; however, the cognitive profile of LRRK2-related PD is not well-characterized. Methods: A cohort of 1,447 PD patients enrolled in the PD Cognitive Genetics Consortium was screened for LRRK2 mutations and completed detailed cognitive testing. Associations between mutation carrier status and cognitive test scores were assessed using linear regression models. Results: LRRK2 mutation carriers (n=29) demonstrated better performance on the Mini Mental State Examination (P=0.03) and the Letter-Number Sequencing Test (P=0.005). A smaller proportion of LRRK2 carriers were demented (P=0.03). Conclusions: Our cross-sectional study demonstrates better performance on certain cognitive tests, as well as lower rates of dementia in LRRK2-related PD. Future longitudinal studies are needed to determine whether LRRK2 mutation carriers exhibit slower cognitive decline.

AB - Background: Increasing evidence suggests that genetic factors play a role in the variability associated with cognitive performance in Parkinson's disease (PD). Mutations in the LRRK2 gene are the most common cause of monogenic PD; however, the cognitive profile of LRRK2-related PD is not well-characterized. Methods: A cohort of 1,447 PD patients enrolled in the PD Cognitive Genetics Consortium was screened for LRRK2 mutations and completed detailed cognitive testing. Associations between mutation carrier status and cognitive test scores were assessed using linear regression models. Results: LRRK2 mutation carriers (n=29) demonstrated better performance on the Mini Mental State Examination (P=0.03) and the Letter-Number Sequencing Test (P=0.005). A smaller proportion of LRRK2 carriers were demented (P=0.03). Conclusions: Our cross-sectional study demonstrates better performance on certain cognitive tests, as well as lower rates of dementia in LRRK2-related PD. Future longitudinal studies are needed to determine whether LRRK2 mutation carriers exhibit slower cognitive decline.

KW - Cognition

KW - LRRK2

KW - Neuropsychological tests

KW - Parkinson's disease

KW - Working memory

UR - http://www.scopus.com/inward/record.url?scp=84927028813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927028813&partnerID=8YFLogxK

U2 - 10.1002/mds.26161

DO - 10.1002/mds.26161

M3 - Article

VL - 30

SP - 728

EP - 733

JO - Movement Disorders

JF - Movement Disorders

SN - 0885-3185

IS - 5

ER -